c ebpβ-lip drug C/EBPβ: The structure, regulation, and its roles in inflammation-related diseases Increasing intratumor C/EBP-β LIP and
Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link c ebp lip drug Continuous Activation of C EBP Transcription Factor Prevents Fibrosis Resolution After Alcohol Cessation Frontiers Emerging functions of C EBP beta Antibody Cell Signaling Technology Purified anti C EBP beta 3 isoforms C EBP beta, LAP, LIP
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17




